Country for PR: United Kingdom
Contributor: PR Newswire Europe
Tuesday, October 15 2019 - 22:00
AsiaNet
Celemics Expedites Target Enrichment NGS Data Insights by Partnering With BlueBee on a Global Genomics Data Solution
SEOUL, South Korea, and RIJSWIJK, The Netherlands, Oct. 15, 2019 /PRNewswire-AsiaNet/ --

    Celemics, provider of NGS target enrichment kits and innovative sequencing 
platforms, announced today the release of a comprehensive NGS target enrichment 
workflow for clinical and translational research applications. To serve as an 
end-to-end workflow with integrated genomic data analysis, Celemics partnered 
with BlueBee, an industrial-grade and highly configurable data platform 
provider, to develop a bioinformatics solution tailored for their assay and 
end-user experience. Collaborative efforts between these two industry leaders 
produced the Celemics web solution, offering a new level of accessibility to 
users of target enrichment NGS assays. The Celemics web solution will act as a 
springboard to propel research towards precision medicine and provide Celemics 
with an extensible, highly efficient and scalable data strategy poised for 
growth. 
    
    Logo: https://mma.prnewswire.com/media/951551/BlueBee_Logo.jpg
    
    The Celemics web solution is a turnkey analytics option, transforming raw 
data into actionable results as part of the Celemics NGS target enrichment kit 
portfolio. "Data analysis is a critical workflow area with potential for 
streamlining," says Dr. Hyoki Kim, CEO Celemics. "We chose BlueBee to address 
the data analysis bottleneck for our customers with a platform that fits 
precisely with our assay. The Celemics web solution standardizes the digital 
end of the workflow, is high-performance, and provides ease of use. This 
strategic product extension is directly in line with our company mission of 
accelerating precision medicine, which we are thrilled to make tangible for a 
global market," Dr. Kim adds. 
    
    Leveraging BlueBee's Genomics Platform, Celemics is able to serve an 
expanding global market with clinical-grade data compliance and guaranteed data 
residency for customers in Europe, Asia, and beyond. The administrator features 
of the platform ensure that Celemics remains in complete control of their 
pipeline and operations. The streamlined user interface enables end-users with 
any level of expertise to analyze, interpret, and return actionable results 
from their sequencing workflow. Celemics end-users may also work 
collaboratively, providing secure, permissioned, and audited access of project 
data and analyses. 
    
    "We are honored to serve Celemics," says Hans Cobben, CEO of BlueBee. "The 
BlueBee Genomics Platform, configured for the Celemics data workflow, will 
streamline data analysis through insight generation for target enrichment 
applications, and support market expansion for Celemics. Partnerships like this 
that bridge the gap between wet-lab and data workflows, are critical to the 
pursuit of precision medicine," Cobben adds. 

    About Celemics
    Celemics is a biotech company developing and supplying key enabling 
solutions in the field of genomics, antibody discovery and synthetic biology. 
As a manufacturer of target enrichment kits for NGS applications, Celemics 
secured itself in the global market for genetic testing. Celemics offers 
defined panels and customized target enrichment kits in IVD and RUO sector with 
remarkable synthetic probe rebalancing technology under stringent quality 
management system (ISO 9001, ISO 13485, GMP). Founded 2010, Celemics has been 
focused in the last several years on providing target enrichment panels in 
Europe and Asia for various applications including oncology, inherited disease 
and genetic marker discovery.

    To learn more, visit www.celemics.com and e-mail support@celemics.com 
    
    Contact person: 
    Brian Park 
    Regional Manager 
    email: brian@celemics.com


    About BlueBee
    BlueBee is a global bioinformatics software solutions provider offering 
fit-for-purpose configurability on its BlueBee Genomics Platform. BlueBee data 
analysis solutions serve to analyze, interpret, report, and learn from 
aggregated data, for research and diagnostic assay manufacturers, 
high-throughput service providers, large project initiatives, and biopharma. 
BlueBee's information security management system is ISO 27001 certified plus an 
option for ISO 13485 quality management to serve medical devices. BlueBee meets 
GDPR and other global data compliance requirements with its data residency 
guarantee.

    For more information about BlueBee visit: www.bluebee.com and follow 
@bluebeegenomics.
    
    Contact person: 
    Michelle Garred 
    VP Global Marketing
    +1-844-662-3511
    email: michelle.garred@bluebee.com
 
    Source: BlueBee Corporation
Translations

Japanese